News

Pharmaceutical Technology on MSN22h
The GLP-1 drug shortage is over. What’s next for the compounders?
Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...
Hosted on MSN1mon
The GLP-1 shortages are over. What happens next?
Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC) explains. Those are critically important functions when shortages of drugs like antibiotics arise or when a patient can’t take a ...
Millions of people are taking compounded weight loss drugs. Now they're about to disappear.
Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC) explains. Those are critically important functions when shortages of drugs like antibiotics arise or when a patient can’t take a ...
Hosted on MSN1mon
These discounted versions of popular weight-loss drugs are going away: What to know
said CEO Scott Brunner. Brunner said patients often must go back to their doctor or telehealth provider and get a new prescription for their weight-loss medications. This transition period gives ...
Weight-Loss Drugs Are Everywhere Now. How the GLP-1 Copycats Took Over.
“We’re going to have patients on the day that those FDA-approved drugs come off the shortage list who are suddenly going to ...
Hosted on MSN1mon
Semaglutide shortage ends as FDA sets deadline for compounders
Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said there is an argument for the premature nature of the shortage resolution, citing the American Society of Health-System Pharmacists ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
Scott Brunner, CEO of the Alliance for Pharmacy Compounding, said that pharmacists have “long known that this shortage had a ...